Improved dosing regimen of temozolomide for treating cancer...

Details Improved dosing regimen of temozolomide for treating cancer... Improved dosing regimen of temozolomide for treating cancer...

A - Human Necessities

61

K

A61K 31/4188 (2006.01) A61K 38/18 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2585446

The use of temozolomide for the manufacture of a medicament for treating cancer in a patient in need of such treating is disclosed comprising administering temozolomide according to improved dosing regimen and/or schedules based on the patient's MGMT level. Additional improved dosing regimen and/or schedules for treating patients with temozolomide are also dislosed.

L'invention concerne des méthodes pour traiter un cancer chez un patient nécessitant un tel traitement. Ces méthodes consistent à administrer du témozolomide selon un schéma posologique et/ou des ordonnancements améliorés fondés sur le niveau de MGMT (O6-méthyle guanine-ADN méthyltransférase) du patient. L'invention concerne également des méthodes améliorées pour traiter des patients à l'aide de témozolomide.

Affiliated with

Also associated with

Rating

Improved dosing regimen of temozolomide for treating cancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved dosing regimen of temozolomide for treating cancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved dosing regimen of temozolomide for treating cancer... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1433043